Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

1 firefighter in cardiac arrest, 2 injured in Bucheon factory fire

One firefighter went into cardiac arrest and two others were injured Friday as they responded to a fire at a factory in Bucheon, just west of Seoul, officials said. The fire broke out at the four-story metal parts coating factory at 8:38 a.m., prompting authorities to dispatch 80 firefighters to combat the blaze. Two firefighters were rushed to hospitals after being isolated as they responded to…

1 firefighter in cardiac arrest, 2 injured in Bucheon factory fire

Firefighters battled an inferno at a four-story metal parts coating factory in Bucheon, Gyeonggi Province, Friday morning. A single firefighter suffered cardiac arrest while responding to the blaze, and two others sustained injuries during the emergency response, officials reported. The fire erupted at 8:38 a.m., prompting the dispatch of 80 firefighters to the scene.

Two of the injured firefighters were airlifted to hospitals, with one of them in critical condition as he was taken to the hospital in a state of cardiac arrest. A third firefighter sustained minor injuries, while two factory officials also reported being harmed. Fire authorities successfully contained the main blaze by 10:22 a.m. and vowed to conduct a comprehensive investigation into the fire's origin once it was completely extinguished.

President Lee Jae Myung, upon being briefed on the incident, urged all-out efforts to extinguish the fire and rescue those in peril. He also called for stringent measures to forestall any further damage, citing the presence of flammable materials within the factory. Special caution was emphasized to safeguard the safety of the firefighters engaged in battling the fire, according to presidential spokesperson Kang Yu-jung.

Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 2 other outlets

Read the original at koreatimes.co.kr →

More in Health & Medicine

LigaChem Doses First Patient in Global Trial of Cancer-Targeting ADC

LigaChem Biosciences has begun global clinical development of its proprietary Claudin 18.2 (CLDN18.2)-targeting antibody-drug conjugate (ADC) candidate, LCB02A. The company announced on Oct.

  • LigaChem begins global Phase 1/2 trial for CLDN18.2-targeting ADC LCB02A on October 15
  • Study involves up to 191 patients with advanced solid tumors expressing CLDN18.2
  • ADC uses LigaChem's ConjuAll platform with exatecan cytotoxic payload

More from Friday 16 October →